These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16756632)

  • 21. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleiotropic effects of thiazolidinediones.
    Rizos CV; Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Expert Opin Pharmacother; 2008 May; 9(7):1087-108. PubMed ID: 18422468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Tang SC; Lai KN
    Clin Immunol; 2009 Aug; 132(2):266-76. PubMed ID: 19443277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pioglitazone and dexamethasone induce adipogenesis in D1 bone marrow stromal cell line, but not through the peroxisome proliferator-activated receptor-gamma pathway.
    Hung SH; Yeh CH; Huang HT; Wu P; Ho ML; Chen CH; Wang C; Chao D; Wang GJ
    Life Sci; 2008 Mar; 82(11-12):561-9. PubMed ID: 18272184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar.
    Spraggs C; McCarthy A; McCarthy L; Hong G; Hughes A; Lin X; Sathe G; Smart D; Traini C; Van Horn S; Warren L; Mosteller M
    Pharmacogenet Genomics; 2007 Dec; 17(12):1065-76. PubMed ID: 18004211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of various diuretic treatments on rosiglitazone-induced fluid retention.
    Karalliedde J; Buckingham R; Starkie M; Lorand D; Stewart M; Viberti G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3482-90. PubMed ID: 17093067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.
    Xiao J; Leung JC; Chan LY; Guo H; Lai KN
    Nephrol Dial Transplant; 2009 Jul; 24(7):2067-77. PubMed ID: 19155534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of thiazolidinediones on differentiation, proliferation, and apoptosis.
    Chou FS; Wang PS; Kulp S; Pinzone JJ
    Mol Cancer Res; 2007 Jun; 5(6):523-30. PubMed ID: 17579114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-specific transgenic and knockout mice.
    Porret A; Mérillat AM; Guichard S; Beermann F; Hummler E
    Methods Mol Biol; 2006; 337():185-205. PubMed ID: 16929948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
    Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
    Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
    J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conditional targeting in the kidney.
    Wu F
    Nephron Physiol; 2007; 107(1):p10-6. PubMed ID: 17657166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diamox, electrolyte & renal changes].
    REAL AP
    Clin Lab (Zaragoza); 1957 Jul; 64(376):33-40. PubMed ID: 13461321
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of adrenal steroids on renal function and electrolyte metabolism.
    SOFFER LJ; GUTMAN A; GELLER J; GABRILOVE JL
    Bull N Y Acad Med; 1957 Oct; 33(10):665-80. PubMed ID: 13460566
    [No Abstract]   [Full Text] [Related]  

  • 37. [Findings on the effect of prednisone on water-electrolyte balance & kidney function in man].
    MERTZ DP; LUTZ-DETTINGER U
    Z Klin Med; 1957; 154(6):631-47. PubMed ID: 13558351
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biochemical basis of pharmaceutical chemistry. 7. Drugs for maintenance of calcium-, fluid volume- and blood sugar homeostasis].
    Nuhn P
    Pharmazie; 1990 Jun; 45(6):448-58. PubMed ID: 2205880
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of mercurial diuretics on renal function and on the principle aspects of hydrosaline balance in cardiac insufficiency].
    PETTINATI L; BERRA A; CERRATO G; MARTINA G
    Minerva Med; 1959 Jun; 50(45):1785-9. PubMed ID: 13674221
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of iodine on body fluid distribution].
    ELLEGAST H; HONETZ N; HUEBER EF
    Wien Klin Wochenschr; 1958 Jun; 70(25):463-5. PubMed ID: 13581662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.